Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NERV compared with CAMP: revenue, margins and what each company keeps, and the suppliers and customers both name
NERV
Minerva Neurosciences, Inc.
Change
Mkt cap
Revenue
Revenue
CAMP
Camp4 Therapeutics Corp
Change
Mkt cap
Revenue
Revenue
vs
Compare
NERV
Minerva Neurosciences, Inc.
vs
CAMP
Camp4 Therapeutics Corp
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
NERV, solid
CAMP, dashed
Supply-chain overlap
Revenue flow
NERV: latest quarter not drawable. CAMP: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only NERV
7
RPRX
Royalty Pharma plc ("Royalty Pharma")
customer
—
Catalent
unlisted
supplier
—
Catalent Germany Schorndorf GmbH
unlisted
supplier
—
Dr. Inderjit Kaul
unlisted
supplier
3 more · NERV chain
›
Shared
0
No shared counterparties.
Only CAMP
7
LLY
Eli Lilly
customer
BMRN
BioMarin Pharmaceutical
customer
FULC
Fulcrum Therapeutics
customer
GSK
GlaxoSmithKline Intellectual Property (No. 3)
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
customer
3 more · CAMP chain
›
NERV
Minerva Neurosciences, Inc.
Change
2.54
▲
+8.09%
· post 2.54
Mkt cap
$112.2M
Revenue
—
Revenue
—
CAMP
Camp4 Therapeutics Corp
Change
3.77
▼
−1.48%
· post 3.77
Closed
Nov 4 '26
Mkt cap
$221.9M
Revenue
$2M
Q2 FY26
Revenue
$3M
FY25
vs
Compare
Closed
Nov 4 '26
NERV
Minerva Neurosciences, Inc.
vs
CAMP
Camp4 Therapeutics Corp
2.54
▲
+8.09%
post 2.54
Price
3.77
▼
−1.48%
post 3.77
$112.2M
Mkt cap
$221.9M
—
Revenue
$2M
Q2 FY26
—
Revenue
$3M
FY25
Change
Change
NERV
2.54
▲
+8.09%
vs
CAMP
3.77
▼
−1.48%
Closed
Nov 4 '26